Athersys To Host First Quarter 2013 Financial Results Call

CLEVELAND, April 18, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its first quarter 2013 financial results at approximately 4:00 PM (Eastern Time) on Tuesday, May 14, 2013, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:
Date May 14, 2013
Time 4:30 p.m. (Eastern Time)
Telephone access: U.S. and Canada 800-273-1254
Telephone access: International 973-638-3440
Access code 43466670
Live webcast www.athersys.com , under the Investors section

A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM (Eastern Time) on May 28, 2013, at the aforementioned URL, or by dialing 800-585-8367 or 855-859-2056 in the U.S. and Canada, from abroad, 404-537-3406, and entering access code 43466670.

About Athersys

Athersys is a clinical stage biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem ® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas. The Company currently has several clinical stage programs involving MultiStem, including for treating inflammatory bowel disease, ischemic stroke, damage caused by myocardial infarction, and for the prevention of graft-versus-host disease. Athersys has also developed a diverse portfolio that includes other technologies and product development opportunities, and has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products. More information is available at www.athersys.com .

The Athersys, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4548 .
CONTACT: William (B.J.) Lehmann, J.D.         President and Chief Operating Officer         Tel: (216) 431-9900         bjlehmann@athersys.com                  Investor Relations:         Lisa M. Wilson         In-Site Communications         Tel: (917) 543-9932         lwilson@insitecony.com

company logo

If you liked this article you might like

Athersys (ATHX) Strong On High Relative Volume Today

Athersys (ATHX) Strong On High Relative Volume Today

Should You Buy Into Athersys’ Latest Spin on Failed Stroke Therapy?

Should You Buy Into Athersys’ Latest Spin on Failed Stroke Therapy?

Here’s Why Athersys (ATHX) Stock is Jumping Today

Here’s Why Athersys (ATHX) Stock is Jumping Today

Athersys (ATHX) Stock Advances on Healios Licensing Agreement

Athersys (ATHX) Stock Advances on Healios Licensing Agreement

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar